United States v. William Waldo Emerson, United States of America v. Scott Wollman, United States of America v. Bruce Ehrlich

846 F.2d 541, 1988 U.S. App. LEXIS 6183
CourtCourt of Appeals for the Ninth Circuit
DecidedMay 10, 1988
Docket86-5267, 86-5274 and 86-5275
StatusPublished
Cited by21 cases

This text of 846 F.2d 541 (United States v. William Waldo Emerson, United States of America v. Scott Wollman, United States of America v. Bruce Ehrlich) is published on Counsel Stack Legal Research, covering Court of Appeals for the Ninth Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
United States v. William Waldo Emerson, United States of America v. Scott Wollman, United States of America v. Bruce Ehrlich, 846 F.2d 541, 1988 U.S. App. LEXIS 6183 (9th Cir. 1988).

Opinions

BOOCHEVER, Circuit Judge:

William Waldo Emerson, Scott Wollman, and Bruce Ehrlich (defendants) appeal their convictions under 21 U.S.C. §§ 841(a)(1) and 846 (1982) for distributing and conspiring to distribute 3,4-methylenedioxymeth-amphetamine, also known as MDMA or Ecstasy (MDMA). Defendants challenge the temporary scheduling of MDMA as a controlled substance by the Administrator of the Drug Enforcement Agency (Administrator) under 21 U.S.C. § 811(h) (Supp.III 1985). We hold that the Attorney General did not properly subdelegate his authority temporarily to schedule drugs to the Administrator and reverse the convictions.

BACKGROUND

Defendants were indicted for their activities involving the distribution of MDMA from or before September 1985 to February 1986. Defendants moved to dismiss the indictment on the ground that the Administrator improperly scheduled MDMA as a temporarily controlled substance. The district court denied the motion. Defendant Emerson then pled guilty to conspiracy to distribute a controlled substance. Defendants Wollman and Ehrlich pled guilty to distribution and conspiracy to distribute a controlled substance. All pleas reserved the right to appeal the court’s order upholding the temporary scheduling of MDMA. The defendants timely appeal to this court under 28 U.S.C. § 1291 (1982).

ANALYSIS

The Controlled Substances Act, Pub.L. No. 91-513, tit. II, 84 Stat. 1242 (1970) (codified as amended at 21 U.S.C. §§ 801-904 (1982 & Supp.III 1985)), prohibits the distribution of a “controlled substance.” 21 U.S.C. § 841(a)(1) (1982). Penalties vary according to the scheduling of the substance. Id. § 841(b) (1982). The scheduling of a particular drug (from Schedule I to V in decreasing order of severity of penalty) depends on the drug’s potential for abuse, its currently accepted medical use in the United States, and its safety for use or potential for dependency. Id. § 812(b) (1982). Congress initially established schedules for a number of substances, id. § 812(c) (1982), and authorized the Attorney General to schedule, transfer between schedules, or remove a substance from a schedule, id. § 811(a) (1982).

[543]*543To add a substance to a schedule under the “permanent” scheduling authority, the Attorney General must find the substance has “a potential for abuse” and make the requisite findings of section 812. Id. § 811(a)(1) (1982). In making these findings, the Attorney General must consider the following factors with respect to each drug:

(1) Its actual or relative potential for abuse.
(2) Scientific evidence of its pharmacological effect, if known.
(3) The state of current scientific knowledge regarding the drug or other substance.
(4) Its history and current pattern of abuse.
(5) The scope, duration, and significance of abuse.
(6) What, if any, risk there is to the public health.
(7) Its psychic or physiological dependence liability.
(8) Whether the substance is an immediate precursor of a substance already controlled under this subchapter.

Id. § 811(c) (1982). The Attorney General must also request an evaluation by the Secretary of Health and Human Services (Secretary). Id. § 811(b) (1982). If after weighing the scientific and medical considerations involved in the above eight factors the Secretary recommends against controlling the drug, the Attorney General must honor that decision. Id. Finally, any scheduling by the Attorney General must be made in accordance with the formal rule-making requirements of the Administrative Procedure Act (APA), 5 U.S.C. §§ 551-559 (1982 & Supp.IV 1986). 21 U.S.C. § 811(a). In 1973, pursuant to authority granted by 21 U.S.C. § 871(a) (1970), the Attorney General delegated the performance of his functions under the Controlled Substances Act to the Administrator. 28 C.F.R. § 0.100(b) (1986).

Congress recognized that permanent scheduling could take from six to twelve months, during which time “enforcement actions against traffickers are severely limited and a serious health problem may arise.” S.Rep. No. 225, 98th Cong., 2d Sess. 264, reprinted in 1984 U.S.Code Cong. & Admin.News 3182, 3446; see also H.R.Rep. No. 835, 98th Cong., 2d Sess., pt. I, at 11-12 (1984). As a result, Congress amended the Controlled Substances Act in 1984 to authorize the Attorney General to schedule substances on an emergency basis without “awaitpng] the exhaustive medical and scientific determinations ordinarily required when a drug is being considered for control.” S.Rep. No. 225, 98th Cong., 2d Sess. 265, reprinted in 1984 U.S.Code Cong. & Admin.News at 3447. The amendment, the Dangerous Drug Diversion Control Act of 1984 (1984 Act), Pub.L. No. 98-473, tit. II, sec. 508, 98 Stat. 2070, 2071-72 (codified at 21 U.S.C. § 811(h) (Supp. Ill 1985)), permits the Attorney General to schedule temporarily in Schedule I a previously unscheduled substance upon finding this action “necessary to avoid an imminent hazard to the public safety.” 21 U.S.C. § 811(h)(1). In making this finding the Attorney General must consider only “those factors set forth in [21 U.S.C. § 811(c)(4), (5), and (6)], including actual abuse, diversion from legitimate channels, and clandestine importation, manufacture, or distribution.” Id. § 811(h)(3). While the Attorney General must transmit proposed orders to the Secretary, he need only “take into consideration any comments submitted by the Secretary.” Id. § 811(h)(4). The temporary scheduling expires at the end of one year, with one six-month extension permitted if the Attorney General has undertaken permanent scheduling efforts pursuant to section 811(a)(1). Id. § 811(h)(2).

On May 31, 1985, acting pursuant to the 1973 delegation and the Attorney General’s temporary scheduling authority under 21 U.S.C. § 811(h), the Administrator issued a notice including an order temporarily scheduling MDMA as a Schedule I controlled substance effective July 1, 1985.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Nolan v. City of New York
S.D. New York, 2024
United States v. Akinyoyenu
199 F. Supp. 3d 106 (District of Columbia, 2016)
United States v. Pickard
100 F. Supp. 3d 981 (E.D. California, 2015)
United States v. Erickson
75 F.3d 470 (Ninth Circuit, 1996)
Michael D. Moehl v. United States
60 F.3d 839 (Federal Circuit, 1995)
Gould v. Aerospatiale Helicopter Corp.
40 F.3d 1033 (Ninth Circuit, 1994)
Butts v. Brown
5 Vet. App. 532 (Veterans Claims, 1993)
United States v. Pickrel
767 F. Supp. 1048 (D. Oregon, 1990)
United States v. Widdowson
723 F. Supp. 583 (D. New Mexico, 1989)
United States v. Loftin
28 M.J. 677 (U S Air Force Court of Military Review, 1989)
United States v. Touby
710 F. Supp. 551 (D. New Jersey, 1989)
Doe v. Nelson
703 F. Supp. 713 (N.D. Illinois, 1988)

Cite This Page — Counsel Stack

Bluebook (online)
846 F.2d 541, 1988 U.S. App. LEXIS 6183, Counsel Stack Legal Research, https://law.counselstack.com/opinion/united-states-v-william-waldo-emerson-united-states-of-america-v-scott-ca9-1988.